The Programme

 

 

Day One
Monday 19 October 2009

9:00

Registration

9:30 Marisa Ehinger
Director New Product Services
ALMAC

Opening remarks from the Chair

Understanding the latest changes in FDA legislation to ensure compliance and speed time to market
9:40

Dr. Brenda Uratani, Ph.D.
Assistant Director
China Office
US Food and Drug Administration
HHS/FDA

Keynote: FDA regulatory update – understanding the key requirements to ensure compliance

  • Outlining the cGMP requirement for Phase 1 and beyond to achieve legislative compliance
  • Highlighting specific issues relating to GMP to ensure compliant clinical manufacturing
  • Ensuring effective quality management when producing investigational products at a global level
MAXIMIZING CLINICAL TRIAL SUPPLY EFFICIENCY USING EFFECTIVE OUTSOURCING STRATEGIES
10:10 Bruce T. Guenter
Senior Director, Global Materials Logistics
WYETH RESEARCH

Boosting clinical trial efficiency by outsourcing clinical logistics to global partners

  • Outlining the decision factors when choosing to outsource clinical logistics
  • Developing steps for building a global alliance with preferred partners
  • Defining SOPs and KPIs
  • Implementing effective service and quality agreements
  • Extending global reach and finding additional cost-cutting opportunities and services by moving from 3PL partnerships to 4PL
  • Advanced temperature control packaging choices for our clinical supplies
  • Establishing 'chain of custody' of our clinical supplies internally and with our global partners
  • Implementing innovative methods to track temperature and location, providing data points for overall supply chain databases
Streamlining clinical trial supply planning operations and using efficient management strategies
10:40 Scott Wong
IVRS Senior Specialist
CELGENE

Maximizing the potential of IVRS to ensure the efficient management of clinical supplies

  • Utilizing IVRS as an inventory management tool, a real-time project information tool and a subject recruitment tool to maximize clinical trial supply efficiency
  • Gaining full business benefits using efficient change management strategies to maximize your clinical trial supply strategies in today’s economic environment
  • Implementing randomization strategies to minimize drug wastage
  • Leveraging your IVR to maximize efficiencies in the clinical supply chain by ensuring supplies are delivered to active sites
  • Using predictive supply strategies to provide for more efficient deliver
11:10

Morning refreshments

11:40 Lekishia White
Vice President
MULTIPHARMA

Proactively preparing for strategic comparator sourcing

  • Determining the sourcing complexity during the design process of the trial
  • Compiling a sourcing strategy – identifying the selection criteria of a comparator sourcing specialist
  • Understanding the unique sourcing criteria of comparators – considerations and how to overcome them
  • Discussing comparator sourcing obstacles and hurdles
12:10 Miguel Feliz
Manager, Protocol Project Management
SCHERING-PLOUGH RESEARCH INSTITUTE

Maximizing clinical supply management by efficient methodologies

  • Source area alignment through tools that promote predictability
  • Governance and structure to facilitate conflict resolution
  • Use of the clinical supply contract to map out expectations
  • Shared accountability and transparency in the process
     
12:40 Kevin Shea
Account Executive
CLINTRAK CLINICAL LaBELING SERVICES

Improving the translatability and efficiency of labeling processes when distributing to multiple international sites

  • Understanding the common challenges in the label text development process
  • How efficient systems can help with translation cycle times
  • Case study using proven systems and processes
  • Techniques for implementing these solutions to maximize labeling process efficiency
01:10

Lunch

UTILIZING GROUND-BREAKING FORECASTING AND SIMULATION TOOLS TO REDUCE CLINICAL TRIAL SUPPLY TIMES
2:10 Chris Popple
Manager, Supply Chain Planning (Clinical)
MEDIMMUNE

Techniques for improving clinical material planning accuracy through forecasting, effective communication and process management

  • Identifying accurate forecasting strategies
  • Outlining available forecasting and simulation tools – balancing pros and cons in order to evaluate the most appropriate tool for your needs
  • Developing teamwork and improving communication channels to ensure success
  • Improving clinical demand planning and operations management coordination
2:40 Chedia Abdelkafi
Director, Clinical Supplies Solutions
N-SIDE

Acceptance and diffusion of clinical supply chain simulation tools: From concepts to demonstrated value

  • Perceived usefulness and Ease-of-Use
  • Usefulness: Addressing practical issues, reducing costs and controlling risk
  • Ease-of-Use: Training, user interface and process
  • Increasing usefulness and Ease-of-Use through integration
3:10

Harp Dhaliwal
Director, Planning and Development Operations
BIOGEN IDEC
and
Ram Narayanan
Associate Director, Clinical Planning and Development Operations
BIOGEN IDEC

Managing the clinical trial supply planning function

  • Increasing scalability - handling more studies with limited resources
  • Supply management on a project lifecycle concept - creating structures for better resource utilization
  • Effective project management and partnerships
  • Minimizing waste while maximizing flexibility
3:40   Afternoon refreshments
4:10 Edward Tourtellotte
President and CEO
Tourtellotte Solutions

Gaining surprisingly positive side-effects when using CTS simulation

  • Outlining kit randomization and packing plans to maximize simulation accuracy
  • Achieving common understanding, QA involvement and efficient training methodologies
  • Setting automatic IVRS specifications to achieve accurate simulation results
  • Understanding enterprise demand all the way up the chain to establish requirements
  • Optimising program designs and outlining lessons learned
  Jim Williams
Director
LODESTONE MANAGEMENT CONSULTANTS
and
Colin Bryant
Director
LODESTONE MANAGEMENT CONSULTANTS

End to end Clinical Trial Supply Management (CTSM) with SAP

  • Overall framework of clinical trial processes - CTSM versus Clinical Trial Management System (CTMS)
  • Identifying business drivers and benefits of CTSM transformation
  • Outlining challenges in CTSM and strategies to overcome them
  • Leveraging SAP to support CTSM processes - planning, packaging & distribution, study design, randomization, order management and IVRS
  • Case study – implementation of CTSM in SAP
    • Project scope
    • Implementation approach
    • Lessons learned
INNOVATIVE PACKAGING, LABELING AND DISTRIBUTION STRATEGIES TO REDUCE COSTS AND MAXIMIZE EFFICIENCY
5:10 Alfredo D'Addio
IM Forecasting and Planning Specialist
CELGENE

Case study: To do or not to do over labeling at the site

  • Celgene’s take on over labeling at sites to manage suppliers efficiently
  • Discussing the pros and cons of over labeling at sites
    • Pro = prolong inventory when shortage of supplies occurs
    • Con = lack of control when utilizing this quick fix method
  • What the steps are if you take the approach and how to maximize the outcome
  • Issues that may arise when over labeling at sites and how to overcome them
  • Ways to prevent over labeling at site by efficient IVR strategies and stability programs
5:40

Closing remarks from the Chair

5:45

Close of Day One

ALMAC drinks reception
At the end of the day one you are invited to attend a drinks reception hosted by our lead sponsor, Almac. Unwind, discuss the day’s presentations and network with your peers.

 
Day Two
Tuesday 20 October 2009
8:30

Registration

9:00 Michael Moorman
Senior Director, Supply Chain Management
PFIZER

Opening remarks from the Chair

9:10 Roundtable morning

Delegates will be able to attend three one-hour roundtable discussion groups from a selection of key topics. Each session will be chaired by an industry expert who will facilitate an exchange of opinions, essential experiences and learning related to a current aspect of clinical trial supply.

 
             
1.

Developing a strategy to blind and package clinical supplies in order to support an “active comparator controlled, randomized, double blind clinical trial”

Identifying the most successful packaging strategies to run comparator and blind trials successfully.

Godson Lomax
Manager Clinical Supplies and Logistics
DAINIPPON SUMITOMO PHARMA AMERICA INC

2.

Gaining full business benefits with efficient change management strategies to maximize your clinical trial supply strategies in today’s economic environment

Optimising your clinical trial supply strategies by adapting to the current economic climate and turning negative impacts into positive effects using economic change management approaches.

Joe Pastorello
Associate Director, Clinical Supply Operations
DAIICHI SANKYO INC

3.

Maximizing the efficiency of the supply chain with IVR/IWR

Achieving clinical trial supply efficiency by utilizing IVR/IWR as accurate forecasting tools.

Marisa Ehinger
Director New Product Services
ALMAC

 
             
4.

Leveraging IVR/IWR systems to support program pooling and removal of use by dates on Clinical Trial Material (CTM)

Enhancing cost and time savings by utilizing IVR/IWR to improve program pooling strategies and expiry date removals.

Lynn Conway
Senior Principal Scientist
PFIZER

5.

Debating effective forecasting and simulation tools to maximize clinical trial supply efficiency

Discussing which simulation and forecasting tools have the potential to improve clinical trial supply efficiency.

Partha S. Banerjee
Director, CMC
MITSUBISHI PHARMA AMERICA

6.

Challenges in blinding unique dosage forms (e.g.inhalers, ointments, syringes, etc.)

Uncovering how to overcome the challenge of blinding materials with comparator products to maximize trial efficiency

Frank Palumbo
Clinical Supplies Program Manager, Global Clinical Supplies Operations
MERCK RESEARCH LABS

 
             
7.

Optimizing clinical supply management by utilizing efficient methodologies

Uncovering efficient methodologies to improve your clinical trial supply management strategies to ensure smooth operations

Miguel Feliz
Manager, Protocol Project Management
SCHERING-PLOUGH RESEARCH INSTITUTE

         
             
12:30

Lunch

DEVELOPING AND IMPLEMENTING ROBUST SUPPLY CHAIN STRATEGIES THAT BALANCE COST, TIME AND RISK
2:00 Michael Moorman
Senior Director, Supply Chain Management
PFIZER

Keynote: Building a supply chain project management core competency

  • The business case for investing in the development supply chain project management core competency
  • Applying the discipline of project management to supply chain projects
  • Leading high performance supply chain project teams
  • Developing and implementing robust supply chain strategies that balance cost, time and risk
ANALYZING GLOBAL REGULATIONS TO ENSURE LEGISLATIVE COMPLIANCE
2:30

Mariam Abdallah
Supply Chain Trial Manager, Clinical Supply Chain
SANOFI-AVENTIS

Case study: Defining import and export regulations, procedures and strategies to run successful global studies

  • Outlining different global import and export requirements to prevent the oversight of key necessities
  • Complying to import and export rules to ensure the smooth running of global clinical trials and on-time distribution
  • Emphasizing the need of standardized global import and export requirements to facilitate compliance
  • Forecasting lead times to ensure accurate planning and to guarantee the smooth operation of global trials
  • Outlining European shipping requirements to ensure efficient logistic and distribution processes
  • Considering shipping times and delays for efficient forecasting of delivers and clinical trial running times
  • Case study: Sanofi-Aventis way of managing import/export in China, Argentina and Turkey
3:00   Afternoon refreshments
3:30 Jeannie Perron
JD, DVM, Of Counsel
COVINGTON & BURLING LLP

Meeting USDA APHIS requirements for importing Clinical Trial Material (CTM)

  • Understanding what clinical trial materials are within USDA APHIS jurisdiction and the types of import documentation required for each
  • Optimizing the availability of imported clinical trial materials through efficient use of USDA National Center for Import and Export resources
  • Recognizing and avoiding potential pitfalls in sourcing clinical trial material from certain countries
  • Knowing where to turn and what to do in dealing with the unexpected import crisis or port hold
OVERCOMING THE HURDLES OF PHASE I SUPPLY CHAIN CHALLENGES TO MAXIMIZE CLINICAL TRIAL EFFICIENCY
4:00 Gail Fisher
Clinical Trial Supply Manager
ASTRAZENECA

Meeting Phase I clinical supply challenges

  • General definitions of a Phase I program
  • Decreasing Phase I program timelines
  • Drug handling
  • Increase efficiencies by defining program versus trial
  • Avoid delays by better planning for imports/exports
  • Risk assessment – refrigerated/frozen products
4:30 Donna McDermott
Worldwide Drug & Biologic Materials Regulatory Compliance Team (WRC)
MERCK

Understanding importing and exporting requirements when shipping clinical materials to run successful global studies

  • Agencies and regulations pertaining to investigational materials
  • Departments involved in processing supplies
  • Identifying potential and final country list to ensure smooth logistic and distribution processes
  • Meeting FDA requirements utilizing 21 CFR 312.120 for exporting non-IND studies
  • How to avoid detention of investigational material when importing to the USA
  • Current FDA communications on importing to US to prevent the oversight of key necessities
5:00

Closing remarks from the Chair

5:05

Champagne prize draw

5:10 Close of conference
  VIBpharma, Arena International Events Group, a trading division of SPG Media Limited. Registered Address:
John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK Registered in England No. 01155599
Email:events@arena-international.com  Privacy Policy | Terms and Conditions | Copyright